Earnings Labs
Enanta Pharmaceuticals, Inc. logo

Enanta Pharmaceuticals, Inc. (ENTA) Earnings Dates & History

NASDAQ·Healthcare·Biotechnology

$13.71

+3.20%

Mkt Cap $309.01M

View all ENTA historical earnings dates, EPS results vs estimates, and post-earnings stock moves. ENTA has 58 quarters of earnings on Earnings Labs, with the most recent call on Monday, February 9, 2026. The next ENTA earnings call is scheduled for Monday, May 11, 2026.

EPS — Estimate vs Actual

Revenue — Estimate vs Actual

Quarterly History

Q1 2026

Feb 9, 2026

$15.90M$18.61M+17.04%-$0.54-$0.42+22.22%
Q4 2025

Nov 17, 2025

$15.97M$15.13M-5.29%-$1.13-$0.87+23.01%
Q3 2025

Aug 11, 2025

$15.97M$18.31M+14.67%-$1.25-$0.85+32.00%
Q2 2025

May 12, 2025

$15.96M$14.93M-6.48%-$1.04-$1.06-1.92%
Q1 2025

Feb 10, 2025

$17.25M$16.96M-1.68%-$1.16-$1.05+9.48%
Q4 2024

Nov 25, 2024

$17.93M$67.64M+277.22%-$1.16-$1.36-17.24%
Q3 2024

Aug 5, 2024

$17.80M$17.97M+0.96%-$1.49-$1.07+28.19%
Q2 2024

May 6, 2024

$16.52M$17.05M+3.23%-$1.26-$1.47-16.67%
Q1 2024

Feb 7, 2024

$21.95M$18.00M-17.98%-$1.18-$1.58-33.90%
Q4 2023

Nov 20, 2023

$20.60M$18.93M-8.10%-$2.11-$1.33+36.97%
Q3 2023

Aug 7, 2023

$20.66M$18.89M-8.56%-$2.38-$1.86+21.85%
Q2 2023

May 8, 2023

$19.18M$17.80M-7.22%-$1.91-$1.79+6.28%
Q1 2023

Feb 7, 2023

$23.55M$23.59M+0.14%-$1.52-$1.39+8.55%
Q4 2022

Nov 21, 2022

$23.13M$20.32M-12.16%-$1.37-$1.27+7.30%
Q3 2022

Aug 8, 2022

$20.65M$19.48M-5.68%-$1.36-$1.53-12.50%
Q2 2022

May 9, 2022

$20.67M$18.72M-9.44%-$1.43-$1.63-13.99%
Q1 2022

Feb 8, 2022

$27.37M$27.65M+1.03%-$1.13-$1.48-30.97%
Q4 2021

Nov 22, 2021

$27.39M$23.57M-13.93%-$1.31-$1.22+6.87%
Q3 2021

Aug 5, 2021

$21.86M$21.62M-1.08%-$1.41-$1.19+15.60%
Q2 2021

May 6, 2021

$17.87M$20.13M+12.64%-$0.94-$1.09-15.96%
Q1 2021

Feb 8, 2021

$41.31M$31.74M-23.16%-$0.82-$0.41+50.00%
Q4 2020

Nov 23, 2020

$12.04M$23.63M+96.28%-$0.92-$0.55+40.22%
Q3 2020

Aug 4, 2020

$22.07M$18.65M-15.48%-$0.73-$0.71+2.74%
Q2 2020

May 6, 2020

$81.94M$27.62M-66.29%-$0.73-$0.30+58.90%
Q1 2020

Feb 6, 2020

$44.48M$52.57M+18.18%$0.55$0.65+18.18%
Q4 2019

Nov 21, 2019

$61.81M$51.31M-16.98%$0.53$0.44-16.98%
Q3 2019

Aug 6, 2019

$34.74M$44.37M+27.70%$0.16$0.33+106.25%
Q2 2019

May 7, 2019

$15.85M$39.63M+150.00%-$0.08$0.20+350.00%
Q1 2019

Feb 6, 2019

$75.48M$69.89M-7.41%$1.35$1.25-7.41%
Q4 2018

Nov 26, 2018

$61.52M$67.20M+9.24%$1.19$1.30+9.24%
Q3 2018

Aug 7, 2018

$57.85M$57.26M-1.02%$0.98$0.97-1.02%
Q2 2018

May 8, 2018

$38.27M$44.05M+15.09%$0.53$0.61+15.09%
Q1 2018

Feb 7, 2018

$12.27M$38.11M+210.52%$0.19$0.59+210.53%
Q4 2017

Nov 20, 2017

$86.95M$75.93M-12.68%$2.13$1.86-12.68%
Q3 2017

Aug 7, 2017

$8.19M$7.51M-8.32%-$0.49-$0.44+10.20%
Q2 2017

May 8, 2017

$12.16M$8.96M-26.32%-$0.38-$0.28+26.32%
Q1 2017

Feb 8, 2017

$7.21M$10.42M+44.40%-$0.15-$0.26-73.33%
Q4 2016

Nov 21, 2016

$19.97M$12.84M-35.71%-$0.11-$0.09+18.18%
Q3 2016

Aug 8, 2016

$20.97M$13.98M-33.34%-$0.13-$0.06+53.85%
Q2 2016

May 9, 2016

$14.44M$13.00M-9.97%$0.13-$0.09-169.23%
Q1 2016

Feb 8, 2016

$40.26M$48.45M+20.34%$1.13$1.36+20.35%
Q4 2015

Nov 23, 2015

$12.04M$14.42M+19.72%$0.15$0.29+93.33%
Q3 2015

Aug 6, 2015

$16.95M$11.60M-31.58%$0.19$0.13-31.58%
Q2 2015

May 7, 2015

$67.77M$57.37M-15.35%$1.76$1.49-15.34%
Q1 2015

Feb 5, 2015

$135.80M$77.50M-42.93%$3.82$2.18-42.93%
Q4 2014

Nov 24, 2014

$3.23M$2.64M-18.27%-$0.33-$0.27+18.18%
Q3 2014

Aug 11, 2014

$38.58M$42.05M+8.98%$1.65$1.81+9.70%
Q2 2014

May 12, 2014

$617.14K$2.16M+250.00%$0.69-$0.28-140.58%
Q1 2014

Feb 13, 2014

$860.33K$893.00K+3.80%-$0.27-$0.30-11.11%
Q4 2013

Nov 25, 2013

$1.57M$1.35M-13.86%-$0.23-$0.25-8.70%
Q3 2013

Aug 12, 2013

$2.37M$1.65M-30.35%-$0.33-$0.23+30.30%
Q2 2013

May 15, 2013

$1.20M-$1.71
Q2 2013

May 8, 2013

$5.28M$27.86M+427.22%-$0.33-$2.28-590.91%
Q3 2012

Sep 30, 2012

$1.86M-$3.50
Q2 2012

Jun 30, 2012

$2.54M-$1.33
Q1 2012

Mar 31, 2012

$36.56M$12.18
Q4 2011

Dec 31, 2011

$741.00K-$0.22
Q3 2011

Sep 30, 2011

-$0.31